Bank of America Merrill Lynch is out with its report today on Albemarle ALB, maintaining Buy.
In a note to clients, Bank of America Merrill Lynch writes, "We are attracted to long-term volume growth in HPC, polyolefin, and biodiesel catalysts. Cyclical recovery and structural improvements in bromine and derivatives support selling price increases. Primary risks are raw material cost inflation and potential for cyclical demand pressure among polymer additives. Our PO of $79 implies shares merit 15.8x our 2012 EPS estimate of $5.00."
At the time of posting, shares of ALB were trading pre-market at $69.10, down 1.16% from Thursday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in